Loading...
Accelerate drug discovery with neurosymbolic AI that decodes disease biology.
BenchSci is a neurosymbolic AI platform for biopharma R&D that decodes disease biology to accelerate drug discovery. It leverages a Biological Evidence Knowledge Graph (BEKG) to integrate diverse scientific data, including proprietary internal data, and offers AI copilots for experimental design and hypothesis generation. Best for large pharmaceutical and biotech companies. Enterprise pricing available.
BenchSci is a neurosymbolic AI platform for biopharma R&D that decodes disease biology to accelerate drug discovery. Its ASCEND platform leverages a Biological Evidence Knowledge Graph (BEKG) and advanced foundation models to provide AI copilots and co-scientists. It integrates diverse scientific data, including publications, multi-omics, and clinical trials, offering a unified view of diseases. Primarily for enterprise biopharma, pricing is custom.
BenchSci's ASCEND platform is the first neuro-symbolic AI platform for biopharma, featuring a Biological Evidence Knowledge Graph (BEKG) that integrates licensed, public, and proprietary internal data. This unique approach, combined with human-in-the-loop curation and multimodal AI, ensures high data quality and mitigates AI hallucinations, enabling complex multi-hop scientific reasoning.
Use Cases
Best For
Complexity
Target Team Size
Target Skill Level
Base Models
Uses Models
Limited Data
Based on 6 data signals
Reflects publicly available data, not an independent audit
Company Size
Dedicated scientific liaisons, Email, Knowledge Base
